These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 24565133

  • 1. SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin.
    Deep G, Jain AK, Ramteke A, Ting H, Vijendra KC, Gangar SC, Agarwal C, Agarwal R.
    Mol Cancer; 2014 Feb 24; 13():37. PubMed ID: 24565133
    [Abstract] [Full Text] [Related]

  • 2. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W, Wang L, Mizokami A, Shi J, Zou C, Dai J, Keller ET, Lu Y, Zhang J.
    Chin J Cancer; 2017 Mar 29; 36(1):35. PubMed ID: 28356132
    [Abstract] [Full Text] [Related]

  • 3. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C.
    World J Gastroenterol; 2015 Jan 07; 21(1):196-213. PubMed ID: 25574092
    [Abstract] [Full Text] [Related]

  • 4. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
    Zhang YP, Liu KL, Yang Z, Lu BS, Qi JC, Han ZW, Yin YW, Zhang M, Chen DM, Wang XW, Li W, Xin H.
    Cell Cycle; 2019 Oct 07; 18(19):2432-2446. PubMed ID: 31448674
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Exosome carrying PSGR promotes stemness and epithelial-mesenchymal transition of low aggressive prostate cancer cells.
    Li Y, Li Q, Li D, Gu J, Qian D, Qin X, Chen Y.
    Life Sci; 2021 Jan 01; 264():118638. PubMed ID: 33164833
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin.
    Zhou Q, Yan B, Hu X, Li XB, Zhang J, Fang J.
    Mol Cancer Ther; 2009 Jun 01; 8(6):1684-91. PubMed ID: 19509250
    [Abstract] [Full Text] [Related]

  • 11. Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.
    Xie D, Gore C, Liu J, Pong RC, Mason R, Hao G, Long M, Kabbani W, Yu L, Zhang H, Chen H, Sun X, Boothman DA, Min W, Hsieh JT.
    Proc Natl Acad Sci U S A; 2010 Feb 09; 107(6):2485-90. PubMed ID: 20080667
    [Abstract] [Full Text] [Related]

  • 12. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y, Cui Z, Li X, Jin X, Peng J.
    Oncotarget; 2017 Apr 18; 8(16):26090-26099. PubMed ID: 28212533
    [Abstract] [Full Text] [Related]

  • 13. Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin.
    Chen L, Mai W, Chen M, Hu J, Zhuo Z, Lei X, Deng L, Liu J, Yao N, Huang M, Peng Y, Ye W, Zhang D.
    Pharmacol Res; 2017 Sep 18; 123():130-142. PubMed ID: 28712972
    [Abstract] [Full Text] [Related]

  • 14. Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4.
    Lan X, Lu G, Yuan C, Mao S, Jiang W, Chen Y, Jin X, Xia Q.
    J Cancer Res Clin Oncol; 2016 Jan 18; 142(1):177-85. PubMed ID: 26206483
    [Abstract] [Full Text] [Related]

  • 15. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
    Al-Azayzih A, Gao F, Somanath PR.
    Biochim Biophys Acta; 2015 May 18; 1853(5):1229-39. PubMed ID: 25746720
    [Abstract] [Full Text] [Related]

  • 16. Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.
    Deep G, Kumar R, Jain AK, Agarwal C, Agarwal R.
    Mutat Res; 2014 Oct 18; 768():35-46. PubMed ID: 25285031
    [Abstract] [Full Text] [Related]

  • 17. Type I collagen down-regulates E-cadherin expression by increasing PI3KCA in cancer cells.
    Cheng JC, Leung PC.
    Cancer Lett; 2011 May 28; 304(2):107-16. PubMed ID: 21377268
    [Abstract] [Full Text] [Related]

  • 18. SPARC Induces E-Cadherin Repression and Enhances Cell Migration through Integrin αvβ3 and the Transcription Factor ZEB1 in Prostate Cancer Cells.
    López-Moncada F, Torres MJ, Lavanderos B, Cerda O, Castellón EA, Contreras HR.
    Int J Mol Sci; 2022 May 24; 23(11):. PubMed ID: 35682554
    [Abstract] [Full Text] [Related]

  • 19. AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling.
    Wang B, Gu Y, Hui K, Huang J, Xu S, Wu S, Li L, Fan J, Wang X, Hsieh JT, He D, Wu K.
    Urol Oncol; 2018 Oct 24; 36(10):472.e11-472.e20. PubMed ID: 30139661
    [Abstract] [Full Text] [Related]

  • 20. Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases.
    Putzke AP, Ventura AP, Bailey AM, Akture C, Opoku-Ansah J, Celiktaş M, Hwang MS, Darling DS, Coleman IM, Nelson PS, Nguyen HM, Corey E, Tewari M, Morrissey C, Vessella RL, Knudsen BS.
    Am J Pathol; 2011 Jul 24; 179(1):400-10. PubMed ID: 21703419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.